Lexapro vs Prozac — Key Takeaways: 5-HT2C Activation, Half-Life, and Picking the Right SSRI

📇 The Index Card — Key Takeaways

Lexapro (Escitalopram) vs Prozac (Fluoxetine)

The case — Benny, 32. Low-drive depression: sleeping ~10 hours a night and waking tired, snacking constantly, gaining weight, foggy, creativity gone — and notably not anxious. He forgets his daily supplements and leans on coffee all morning. He needs activation, not calm.

1. Prozac's signature move: 5-HT2C blockade. That receptor normally puts a brake on dopamine and norepinephrine release in the prefrontal cortex. Fluoxetine blocks the brake — so drive, energy, and motivation come up, with a touch of appetite suppression on the side. Lexapro has no meaningful 5-HT2C action.
2. Read the cravings. Benny's coffee habit is a clinical clue: patients gravitate toward the physiology they're missing. A flat, hypersomnic patient hunting for stimulation all morning is telling you which direction to prescribe.
3. Half-life is an exit strategy. Fluoxetine runs 4–6 days with chronic dosing, and its active metabolite norfluoxetine lasts 4–16 days — it practically tapers itself, a gift for a patient scarred by a brutal short-half-life taper. Escitalopram's 27–32 hours wash out in days. The trade: Prozac's side effects linger just as long, and steady state takes longer to arrive.
4. 'Clean' is Lexapro's superpower. Among the highest serotonin-transporter affinities of any SSRI, and the most SERT-selective — plus a second, allosteric binding site that works like a double lock — keeps serotonin tone steady instead of swinging. Minimal CYP interference, no histamine fog, no anticholinergic drag: the pick for older patients and polypharmacy, and among the best-tolerated SSRIs in the literature.
5. Prozac's tax: CYP2D6. Fluoxetine is a potent CYP2D6 inhibitor (its CYP3A4 inhibition is weak and not usually clinically significant) — it can push up levels of aripiprazole, risperidone, and haloperidol, blunt codeine and tramadol, and cut tamoxifen's effectiveness. It earns its place only after the whole med list has been checked.
6. The label isn't close. Fluoxetine: MDD, OCD, panic disorder, PMDD, bulimia nervosa at the 60 mg dose (that 5-HT2C effect again — the episode's proposed link to impulsivity), and combination approvals for bipolar depression and treatment-resistant depression. Escitalopram: MDD and generalized anxiety disorder.

The call for Benny: Prozac 10 mg, up to 20 mg after one week. And the episode's closing pearl — the best antidepressant is the one your patient will actually take. Tolerability beats textbook elegance, every time.